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KD= 12.9 nM 

























































































































































































































































































interactions.!Data!are!presented!as!mean!values!of!triplicate!measures!with!n=3.!! NGF! ProNGF!PD90780! 110!µM!(CI=!938129!µM)! 9.4!µM!(CI=!5.7816!µM)!BVNP!1! 104!µM!(CI=!938117!µM)! Not!Determined!BVNP!3! Not!Determined! 29!µM!(CI=!17850!µM)!BVNP!4! Not!Determined! 21!µM!(CI=!12836!µM)!BVNP!6! 2.2!µM!(CI=!1.583.3!µM)! Not!Determined!BVNP!7! 1.1!µM!(CI=!0.781.6!µM)! Not!Determined!
)
)
)
)
)
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Discussion&! In!the!present!study,!we!determined!the!affinity!of!proNGF!for!the!p75NTR!receptor!using!novel!methodology.!!In!addition,!we!have!characterized!the!ability!of!both!known!and!novel!inhibitors!to!block!proNGF8p75NTR!interactions.!!Further,!we!assessed!the!ligand!specificity!of!the!inhibitors!through!the!characterization!of!their!ability!to!inhibit!NGF!from!interacting!with!p75NTR.!!!
! Several!pathological!conditions!exist!where!dysregulation!of!both!neurotrophins!and!proneurotrophins!have!been!implicated.!!More!specifically,!signaling!of!both!NGF!and!proNGF!through!the!p75NTR!receptor!has!been!shown!to!induce!apoptosis!leading!to!neuronal!death,!which!may!result!in!neurodegenerative!disease,!depending!on!the!neuronal!population!affected!(Kenchappa!et!al.,!2010).!!!
! Historically,!proNGF!inhibition!strategies!have!focused!on!modulating!the!p75NTR!receptor,!as!opposed!to!proNGF!(Massa!et!al.,!2006).!!For!instance,!LM11A831,!a!small,!nonpeptide!p75NTR!ligand!has!been!shown!to!induce!survival!signaling!and!inhibit!proNGF8induced!death!(Massa!et!al.,!2006).!!More!recently,!this!small!molecule!has!been!found!to!reverse!the!cholinergic!neurite!dystrophy!in!Alzheimer’s!disease!mouse!models!through!its!binding!and!modulation!of!the!p75NTR!receptor!(Simmons!et!al.,!2014).!!Another!approach!to!the!inhibition!of!proNGF8mediated!apoptotic!signaling!is!through!the!reduction!of!proNGF!synthesis!in!the!central!nervous!system.!!Studies!have!found!that!minocyline,!a!derivative!of!tetracycline,!is!able!to!offer!neuroprotective!effects!in!experimental!models!of!neurodegenerative!diseases!(Simmons!et!al.,!2014).!!Specifically,!it!has!been!shown!that!minocycline!
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significantly!reduces!the!production!of!proNGF!in!microglia!both!in*vitro!and!in*vivo!through!the!inhibition!of!the!phosphorylation!of!p38MAPK!(Simmons!et!al.,!2014).!!While!these!therapeutic!strategies!show!early!promise,!their!clinical!relevance!has!not!yet!been!investigated.!!!
Drug!discovery!efforts!to!inhibit!NGF8mediated!signaling!have!focused!on!inhibiting!its!interaction!with!the!TrkA!receptor.!!For!example,!the!use!of!NGF8mimetic!peptides,!which!bind!the!TrkA!receptor!in!the!same!manner!as!NGF,!but!do!not!elicit!downstream!signaling,!have!been!described!previously!(Eibl!et!al.,!2012).!!Unfortunately,!peptide8based!strategies!have!not!proven!effective!in!clinical!settings!(Eibl!et!al.,!2012).!!More!recently,!the!humanized!monoclonal!antibody,!Tanezumab,!has!demonstrated!promising!therapeutic!potential!for!the!treatment!of!chronic!pain,!including!conditions!such!as!osteoarthritis!(Cattaneo,!2010).!!While!there!have!been!a!number!of!safety!concerns,!such!as!adverse!changes!to!the!sympathetic!nervous!system!and!osteonecrosis!of!joint!tissue,!partial!clinical!holds!on!this!antibody8mediated!therapy!were!lifted!earlier!this!year!(Cattaneo,!2010;!Garber,!2011).!!!
! While!antibody8mediated!therapies!have!shown!promise!in!clinical!settings,!these!therapeutics!remain!highly!specific!and!are!unable!to!cross!the!blood8brain!barrier.!!Further,!the!production!of!these!therapies!is!both!technically!and!economically!challenging.!!Conversely,!small!molecules!may!be!of!high!clinical!interest!as!they!are!generally!easy!to!synthesize,!are!cost8effective,!and!benefit!from!oral!activity.!
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Previously,!five!small!molecule!inhibitors!known!to!block!NGF8TrkA!interactions!have!been!described!(ALE80540,!PD90780,!Ro!0882750,!PQC!083,!and!Y1036)!(Jaen!et!al.,!1995;!Owolabi!et!al.,!1999;!Niederhauser!et!al.,!2000;!Colquhoun!et!al.,!2004;!Hefti!et!al.,!2006;!Eibl!et!al.,!2010;!Eibl!et!al.,!2013).!!Recently,!the!ability!of!four!of!these!compounds!(ALE80540,!PD90780,!Ro!0882750,!and!PQC!083)!to!inhibit!both!NGF8!p75NTR!and!NGF8TrkA!interactions!has!been!evaluated!using!SPR!spectroscopy!(Sheffield!et!al.,!2015).!!These!small!molecules!bind!NGF,!as!opposed!to!the!TrkA!and!p75NTR!receptors,!in!order!to!modulate!NGF!dysregulation.!!Of!these!small!molecules,!PD90780!was!found!to!be!the!most!effective!at!inhibiting!both!NGF8TrkA!and!NGF8p75NTR!interactions!(Sheffield!et!al.,!2015).!!To!date,!no!small!molecule8based!approaches!to!the!inhibition!of!proNGF8p75NTR!interactions!have!been!performed.!
! Our!study!provides!the!first!characterization!of!the!ability!of!known!NGF!inhibitors!ALE80540,!PD90780,!Ro!0882750,!and!PQC!083!to!inhibit!the!binding!of!proNGF!to!the!p75NTR!receptor.!!Our!findings!indicate!that!of!the!previously!reported!inhibitors,!PD90780!offered!the!most!inhibitory!action!for!proNGF!binding!p75NTR,!while!ALE80540!and!Ro!0882750!only!mildly!blocked!this!interaction.!!The!ability!of!these!compounds!to!inhibit!proNGF!from!binding!p75NTR!is!similar!to!their!inhibitory!action!of!NGF8p75NTR!interactions.!!For!example,!of!the!known!compounds,!PD90780!was!found!to!be!the!most!effective!inhibitor!of!NGF8p75NTR!interactions,!while!both!ALE80540!and!Ro!0882750!were!found!to!offer!only!mild!inhibition!of!this!interaction!(Sheffield!et!al.,!2015).!!The!enhanced!inhibition!of!PD90780!on!proNGF8p75NTR!interactions,!in!comparison!to!its!inhibitory!action!on!
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NGF8p75NTR!interactions,!may!likely!be!due!to!the!structural!differences!between!NGF!and!proNGF,!which!allows!for!altered!binding!of!the!small!molecule!to!the!ligand.!!Further,!consistent!with!previous!findings,!we!found!that!PQC!083!yielded!experimental!artifacts!in!the!form!of!non8specific!binding!and!was!difficult!to!characterize!using!SPR!spectroscopy.!!Of!particular!interest,!our!results!suggest!that!PD90780!may!offer!multipotent!inhibition,!as!it!is!able!to!inhibit!both!neurotrophin!and!proneurotrophin8receptor!interactions.!
! The!characterization!of!the!ability!of!the!novel!derivatives!of!ALE80540!to!inhibit!both!NGF!and!proNGF!binding!to!p75NTR!revealed!several!ligand!specific!molecules.!!For!example,!BVNP!1,!BVNP!6,!and!BVNP!7!were!shown!to!be!effective!inhibitors!of!NGF8p75NTR!interactions,!while!these!compounds!only!mildly!blocked!proNGF!from!binding!p75NTR.!!Of!these!compounds,!both!BVNP!6!and!BVNP!7!offered!low!micromolar!inhibitory!action!(2.2!µM!and!1.1!µM,!respectively),!while!the!inhibition!of!BVNP!1!was!found!to!be!in!the!high!micromolar!range!(104!µM).!!Conversely,!BVNP!3!and!BVNP!4!were!found!to!be!specific!for!the!inhibition!of!proNGF8p75NTR!interactions.!!Both!BVNP!3!and!BVNP!4!were!found!to!have!inhibitory!effects!in!the!low8to8mid!micromolar!range!with!IC50!values!of!29!µM!and!21!µM,!respectively.!
Finally,!through!steady8state!analysis,!the!affinity!of!proNGF!for!the!p75NTR!receptor!was!determined!to!be!23.5!±!0.4!nM,!which!is!consistent!with!previous!reports!in!the!literature.!!!Using!a!combination!of!kinetic!studies!and!SPR!spectroscopy,!Nykjaer!et!al.!(2004)!reported!an!affinity!of!15!nM!for!proNGF8p75NTR!
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binding.!!Though!the!methodology!between!studies!varies,!both!analyses!conclude!that!the!interaction!between!proNGF!and!p75NTR!is!low!affinity!in!nature.!!!Further,!previous!steady8state!analyses!have!revealed!that!binding!between!NGF!and!p75NTR!has!an!affinity!of!13!nM!(Sheffield!et!al.,!2015).!!The!reduced!affinity!of!the!proNGF8p75NTR!interaction,!in!comparison!to!the!interaction!between!NGF!and!p75NTR,!is!due!to!lack!of!processing!of!the!precursor!protein!(Nykjaer!et!al.,!2004).!!!
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Conclusions&Known!small!molecule!inhibitors!ALE80540,!PD90780,!Ro!0882750,!and!PQC!083!were!assessed!on!their!ability!to!block!proNGF!from!binding!p75NTR!using!SPR!spectroscopy.!!In!addition,!novel!bivalent!naphthalimide!derivatives!of!ALE80540!were!evaluated!for!their!effectiveness!to!inhibit!binding!of!both!NGF!and!proNGF!to!the!p75NTR!receptor.!!Of!the!known!inhibitors,!PD90780!was!found!to!offer!the!most!effective!inhibitory!action!for!proNGF8p75NTR!interactions,!which!suggests!that!this!compound!offers!multipotent!inhibition,!as!it!is!capable!of!blocking!both!neurotrophin!and!proneurotropin8receptor!interactions.!!!The!analysis!of!novel!compounds!revealed!several!ligand!specific!molecules.!!BVNP!1,!BVNP!6,!and!BVNP!7!were!shown!to!be!effective!inhibitors!of!NGF8p75NTR!interactions,!while!BVNP!3!and!BVNP!4,!on!the!other!hand,!were!found!to!be!selective!for!the!inhibition!of!proNGF!binding!to!p75NTR.!!The!identification!of!novel!compounds!capable!of!inhibiting!p75NTR8mediated!apoptotic!signaling!may!have!implications!for!the!treatment!of!neurodegenerative!diseases,!such!as!Alzheimer’s!disease.!!Furthermore,!these!molecules!may!serve!as!a!starting!point!for!the!development!of!NGF!and!proNGF!specific!inhibitors.!!To!develop!the!promising!outcomes!of!this!work,!investigations!with!both!primary!cell!culture!and!animal!models!are!now!needed!to!assess!the!suitability!of!these!bivalent!naphthalimide!compounds!for!potential!lead!development.!
)
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Chapter&5:&Conclusions&and&Future&Directions&!! Neurotrophins!are!a!unique!family!of!soluble!signaling!proteins,!which!act!to!influence!the!proliferation,!differentiation,!and!survival!of!neurons!in!the!central!and!peripheral!nervous!systems!(Cai!et!al.,!2014).!These!proteins!are!initially!synthesized!as!precursors!known!as!proneurotrophins,!which!haven!been!reported!to!act!as!distinct!ligands!with!biological!functions!beyond!their!role!as!precursors!(Fahnestock!et!al.,!2004;!Hempstead,!2014).!!
The!dysregulation!of!both!neurotrophins!and!proneurotrophins!have!been!implicated!in!several!pathologies.!For!instance,!NGF,!the!most!widely!studied!member!of!the!neurotrophin!family,!has!been!reported!to!have!involvement!in!both!inflammatory!and!neuropathic!pain!states!through!increased!TrkA8mediated!signaling!(Chao!et!al.,!2006;!Pezet!&!McMahon,!2006;!Dray,!2008).!In!addition,!NGF!dysregulation!has!been!implicated!in!the!development!and!progression!of!neurodegenerative!disease!states!(i.e.!Parkinson’s!and!Alzheimer’s!diseases)!through!increased!binding!to!the!p75NTR!receptor,!which!has!been!shown!to!induce!apoptosis!leading!to!neuronal!death!(Kenchappa!et!al.,!2010).!!Similarly,!dysregulation!of!the!NGF!precursor!protein,!proNGF,!has!been!implicated!in!neurodegeneration!through!p75NTR8mediated!apoptotic!signaling!(Fahnestock!et!al.,!2001;!Lee!et!al.,!2001;!Beattie!et!al.,!2002;!Song!et!al.,!2010).!!Further,!several!studies!have!reported!that!proNGF!dysregulation!is!implicated!in!breast!cancer,!following!myocardial!infarction,!and!psoriasis!(Hempstead,!2014).!Therefore,!
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therapeutic!strategies!to!inhibit!both!NGF!and!proNGF!signaling!may!be!of!significant!clinical!interest.!
Drug!discovery!efforts!to!modulate!NGF!and!proNGF!signaling!vary.!Several!approaches!to!the!inhibition!of!NGF!have!been!investigated,!including!both!NGF8mimetic!peptides!and!human!monoclonal!antibody!therapeutics.!While!NGF8mimetics!have!shown!initial!biochemical!promise,!they!have!not!yet!been!successful!in!clinical!settings!(Eibl!et!al.,!2012).!The!most!successful!anti8NGF!antibody,!Tanezumab,!is!the!first!NGF!inhibitor!to!advance!to!clinical!trials.!Unfortunately,!due!to!the!number!of!safety!concerns!associated!with!the!use!of!this!therapeutic,!clinical!investigations!of!this!compound!were!suspended.!Earlier!this!year,!however,!partial!clinical!holds!on!this!antibody8mediated!therapy!were!lifted,!resulting!in!a!sizeable!advancement!in!the!field!of!neurotrophin8related!therapeutics!(Cattaneo,!2010;!Garber,!2011).!!
Investigations!into!the!inhibition!of!proNGF8mediated!signaling!are!limited.!One!such!approach!utilizes!a!small,!nonpeptide!p75NTR!ligand,!LM11A831.!This!compound!has!been!reported!to!prevent!proNGF8induced!death!and!reverse!the!cholinergic!neurite!dystrophy!in!Alzheimer’s!disease!mouse!models!(Simmons!et!al.,!2014).!Another!strategy!for!the!inhibition!of!proNGF8mediated!signaling!involves!reducing!the!amount!of!proNGF!synthesized!in!the!central!nervous!system!through!the!administration!of!minocycline,!a!derivative!of!tetracycline!(Yune!et!al.,!2007).!While!each!of!these!strategies!have!shown!early!potential,!no!therapeutics!directed!at!the!inhibition!of!proNGF!have!made!it!to!clinical!trial.!
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Traditionally,!drug!discovery!efforts!have!focused!on!binding!to!and!modulating!the!receptors,!as!opposed!to!the!ligand.!!The!use!of!small!molecules!to!target!a!ligand,!such!as!NGF,!rather!than!a!receptor,!such!as!p75NTR!or!TrkA,!is!a!relatively!novel!pharmacological!strategy.!To!date,!five!of!these!inhibitors!have!been!discovered!and!described!in!the!literature!(Jaen!et!al.,!1995;!Owolabi!et!al.,!1999;!Niederhauser!et!al.,!2000;!Colquhoun!et!al.,!2004;!Hefti!et!al,!2006;!Eibl!et!al.,!2013).!!However,!while!these!small!molecule8based!NGF!binding!agents!are!known!NGF8TrkA!inhibitors,!their!ability!to!block!NGF!from!interacting!with!p75NTR!had!not!yet!been!assessed.!Further,!these!compounds!had!never!been!investigated!using!SPR!spectroscopy,!a!tool!which!has!been!proven!to!be!extremely!suitable!for!use!in!drug!discovery!applications!and!the!characterization!of!small!molecules,!such!as!the!NGF!inhibitors!discussed!previously!(Willander!&!Al8Hilli,!2009;!Piliarik!et!al.,!2009).!This!thesis!provides!the!first!evaluation!of!the!ability!of!these!compounds!to!block!NGF!binding!to!p75NTR.!Of!the!previously!reported!NGF!inhibitors,!only!PD90780!was!effective!at!inhibiting!the!interaction!of!NGF!with!p75NTR,!which!suggests!receptor!selectivity!between!known!NGF!inhibitors.!The!pharmacological!advantages!of!receptor8selective!inhibition!are!obvious,!as!signaling!through!each!receptor,!either!p75NTR!or!TrkA,!results!in!markedly!different!outcomes,!which!are!associated!with!distinct!pathologies.!
Therapeutics!that!bind!to!and!modulate!proNGF!had!not!yet!been!investigated.!Compounds!which!are!able!to!block!the!interaction!of!proNGF!and!p75NTR!offer!potential!for!the!treatment!of!several!conditions,!including!neurodegenerative!diseases,!such!as!Parkinson’s!and!Alzheimer’s!diseases.!
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Interestingly,!the!ability!of!the!known!NGF!inhibitors!to!also!block!proNGF8mediated!signaling!has!not!been!evaluated!previously.!To!this!end,!a!study!investigating!the!ligand!selectivity!of!these!compounds!was!conducted.!As!with!its!inhibitory!action!on!NGF8p75NTR!interactions,!PD90780!was!found!to!offer!the!most!effective!inhibition!of!proNGF!binding!to!p75NTR.!These!results!suggest!that!this!compound!offers!multipotent!inhibition,!as!it!is!capable!of!blocking!both!neurotrophin!and!proneurotropin8receptor!interactions.!Multipotent!compounds!such!as!this!may!have!potential!clinical!application!for!the!treatment!of!neurodegenerative!diseases,!such!as!Alzheimer’s!disease,!where!dysregulation!of!both!NGF!and!proNGF!have!been!implicated.!
Furthermore,!there!is!a!potential!need!for!compounds!with!the!ability!to!selectively!inhibit!either!NGF!or!proNGF8mediated!signaling.!As!such,!novel!bivalent!naphthalimide!derivatives!of!known!NGF!inhibitor,!ALE80540,!were!evaluated!for!ligand!selectivity!through!the!examination!of!their!ability!to!block!both!NGF!and!proNGF!from!binding!the!p75NTR!receptor.!Investigations!revealed!several!ligand!specific!compounds.!For!instance,!BVNP!1,!BVNP!6,!and!BVNP!7,!which!were!shown!to!be!effective!inhibitors!of!NGF8p75NTR!interactions,!while!BVNP!3!and!BVNP!4!were!found!to!be!selective!for!the!inhibition!of!proNGF!binding!to!p75NTR.!
The!studies!presented!in!this!thesis!offer!new!insight!into!the!use!of!small!molecule!inhibitors!to!block!both!neurotrophin!and!proneurotrophin8mediated!signaling.!Several!opportunities!exist!for!the!use!of!these!compounds!in!the!
!! !
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treatment!of!various!pathologies,!including!both!neuropathic!and!inflammatory!pain!states,!and!neurodegenerative!disease!states.!! !
While,!in!recent!years,!progress!has!been!made!in!the!understanding!of!the!vast!utility!of!these!compounds!for!experimental!purposes,!several!studies!are!needed!before!these!molecules!undergo!clinical!investigation.!For!example,!primary!cell!culture!studies!will!be!needed!in!order!to!assess!the!toxicity!and!bioavailability!of!these!inhibitors,!in!addition!to!pre8clinical!trials!using!animal!models!before!investigations!on!human!participants!can!be!established.!Finally,!investigations!of!the!ability!of!both!the!known!and!novel!small!molecule!inhibitors!to!block!proNGF8sortilin!interactions!may!act!to!further!expand!the!knowledge!basis!surrounding!proNGF!inhibition!and!the!use!of!these!bivalent!naphthalimide!compounds!for!potential!lead!development.!
!!!!!!!!!!!!
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